Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$80.7M Sell
333,370
-28,425
-8% -$6.55M 5.27% 5
2026
Q1
$77.6M Sell
361,795
-17,185
-5% -$3.82M 5.88% 3
2025
Q4
$77.8M Buy
378,980
+2,110
+0.6% +$411K 6.13% 4
2025
Q3
$70.9M Sell
376,870
-24,011
-6% -$4.42M 5.77% 4
2025
Q2
$72.5M Buy
400,881
+33,887
+9% +$5.83M 5.84% 4
2025
Q1
$63.2M Buy
366,994
+7,666
+2% +$1.39M 5.56% 6
2024
Q4
$64.8M Sell
359,328
-36,777
-9% -$6.7M 4.87% 5
2024
Q3
$68M Buy
396,105
+112,068
+39% +$18.7M 5.03% 9
2024
Q2
$47.4M Buy
+284,037
New +$49.1M 3.4% 15

Other funds holding AME

M.D. Sass LLC's AME Position: Q2 2026 in Review

M.D. Sass LLC reduced its Ametek (AME) stake by 7.9% in Q2 2026, selling an estimated $6.55M and leaving 333,370 shares worth $80.7M. The position accounts for 5.27% of the portfolio, ranked #5.

M.D. Sass LLC first reported a position in AME in Q2 2024 and has held it in 9 quarters since. 1,196 funds tracked by Wall St. Rank hold AME as of Q2 2026.

  • M.D. Sass LLC held 333,370 shares of Ametek worth $80.7M as of Q2 2026.
  • M.D. Sass LLC sold 28,425 Ametek shares in Q2 2026, an estimated $6.55M.
  • Ametek made up 5.27% of M.D. Sass LLC's portfolio in Q2 2026, its #5 holding.
  • M.D. Sass LLC first reported a position in Ametek in Q2 2024 and has held it in 9 quarters since.
  • 1,196 funds tracked by Wall St. Rank held Ametek as of Q2 2026.

Based on M.D. Sass LLC's 13F filing for Q2 2026, filed 7 Aug 2026.